Citadel Advisors »

Acelyrin shares owned by Citadel Advisors

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $49M 6.6M 7.46
2023-09-30 $62M 6.0M 10.17
2023-06-30 $126M 6.0M 20.90

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
Opaleye Management
OrbiMed Advisors
venBio Partners
Jpmorgan Chase & Co
Artal Group
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management
Goldman Sachs Group

View all funds holding Acelyrin